Cycad Group

Cycad Group operates as a venture capital firm, strategically investing in companies developing enabling solutions, disruptive technologies, and innovative products. The firm maintains an opportunistic investment strategy but specifically targets opportunities within life sciences, including therapeutics, medical devices, and diagnostics, alongside energy technologies and advanced materials. Cycad Group engages across all development stages, from initial outside financing to later-stage transactions, emphasizing a deep understanding of technology, market potential, and management teams.

The firm was co-founded in 2000 by Mark R. Collins, Paul F. Glenn, and K. Leonard Judson. Paul F. Glenn serves as Chairman & Director, while K. Leonard Judson holds the position of President & Managing Director, bringing substantial experience to the firm's leadership. Their collective insight centered on identifying and supporting entrepreneurial ventures poised to leverage technological advancements.

Cycad Group partners with exceptional entrepreneurs driving technology-driven businesses. The firm's overarching vision is to cultivate significant growth in its portfolio companies, meticulously analyzing the fundamental aspects of technology, market opportunities, and associated risks. They are committed to fostering innovative enterprises that contribute to key sectors.